MR assessment of radiation-induced blood-brain barrier permeability changes in rat glioma model

AJNR Am J Neuroradiol. 1994 Apr;15(4):625-32.

Abstract

Purpose: To assess the potential of a T1-weighted, gadolinium-enhanced MR technique for quantifying radiation-induced changes of blood-brain barrier permeability in a model of stereotactically implanted intracerebral gliomas in rats.

Methods: We calculated the gadolinium blood-to-tissue transport coefficient for gadopentetate dimeglumine from signal intensities in sequential MR images in nine control animals that were not irradiated and in five and three animals that had received 2500 cGy and 1500 cGy whole-brain irradiation, respectively, at 2 days before imaging.

Results: The average blood-to-tissue transport coefficient values were 9.76 mL.kg-1.min-1 in the control group, 23.41 mL.kg-1.min-1 in the 2500 cGy group, and 25.63 mL.kg-1.min-1 in the 1500-cGy group. Blood-to-tissue transport coefficients were significantly higher after irradiation, indicating increased radiation-induced blood-brain barrier permeability. Similar increased blood-brain barrier leakiness in brain tumors after high-dose irradiation has been shown by previous nuclear medicine studies using quantitative autoradiography.

Conclusion: Contrast-enhanced dynamic MR of brain gliomas is a sensitive method to document radiation-induced blood-brain barrier breakdown. Quantitative gadolinium-enhanced MR may become a useful tool for the management of patients with brain tumors undergoing radiation therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Astrocytoma / metabolism*
  • Astrocytoma / radiotherapy*
  • Blood-Brain Barrier / radiation effects*
  • Brain / metabolism
  • Brain / radiation effects
  • Brain Neoplasms / metabolism*
  • Brain Neoplasms / radiotherapy*
  • Capillary Permeability / radiation effects
  • Contrast Media / administration & dosage
  • Contrast Media / pharmacokinetics
  • Drug Combinations
  • Gadolinium / administration & dosage
  • Gadolinium / blood
  • Gadolinium / pharmacokinetics
  • Gadolinium DTPA
  • Image Enhancement
  • Infusions, Intravenous
  • Magnetic Resonance Imaging*
  • Male
  • Meglumine / administration & dosage
  • Meglumine / pharmacokinetics
  • Organometallic Compounds / administration & dosage
  • Organometallic Compounds / pharmacokinetics
  • Pentetic Acid / administration & dosage
  • Pentetic Acid / analogs & derivatives
  • Pentetic Acid / pharmacokinetics
  • Permeability / radiation effects
  • Radiotherapy Dosage
  • Radiotherapy, High-Energy
  • Rats
  • Rats, Inbred F344
  • Tissue Distribution
  • Tumor Cells, Cultured

Substances

  • Contrast Media
  • Drug Combinations
  • Organometallic Compounds
  • Meglumine
  • Pentetic Acid
  • Gadolinium
  • Gadolinium DTPA